Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02706691
Title Pan FGFR Kinase Inhibitor BGJ398 in Treating Patients With FGFR1-3 Translocated, Mutated, or Amplified Recurrent Head and Neck Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Chicago
Indications

nasopharynx carcinoma

head and neck squamous cell carcinoma

Therapies

Infigratinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST